Increased cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate from systemic sclerosis patients

Rheumatology

Volumn 49, Issue 12, 2010, Pages 2322-2326

  Tufvesson, Ellen ^a   Bozovic, Gracijela ^a   Hesselstrand, Roger ^a   Bjermer, Leif ^a   Scheja, Agneta ^a   Wuttge, Dirk M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

8 Isoprostane; Exhaled breath condensate; Fibrosis; High resolution computer tomography; Leukotriene; Oxidative stress; Systemic sclerosis; Traction bronchiectasis

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; BUDESONIDE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LUNG FIBROSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIODIAGNOSIS; SYSTEMIC SCLEROSIS;

ADULT; AGED; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; CYSTEINE; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOLOGIC FACTORS; ISOPROSTANES; LEUKOTRIENES; MALE; MIDDLE AGED; OXIDATIVE STRESS; SCLERODERMA, SYSTEMIC;

EID: 78549293294     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq271     Document Type: Article

References (20)

1. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
2. Matucci-Cerinic M, D'Angelo S, Denton CP, Vlachoyiannopoulos P, Silver R. Assessment of lung involvement. Clin Exp Rheumatol 2003;21(3 Suppl. 29): S19-23.
3. Kowal-Bielecka O, Kowal K, Distler O et al. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis Rheum 2005;52:3783-91.
4. Kowal-Bielecka O, Distler O, Kowal K et al. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease. Arthritis Rheum 2003;48:1639-46.
5. Hackshaw KV, Voelkel NF, Thomas RB, Westcott JY. Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus. J Rheumatol 1992; 19:252-8.
6. Montuschi P, Ciabattoni G, Paredi P et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998;158: 1524-7.
7. Morrow JD. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 2006;12: 895-902.
8. Ogawa F, Shimizu K, Muroi E et al. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology 2006; 45:815-8.
9. Stein CM, Tanner SB, Awad JA, Roberts LJ, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996;39: 1146-50.
10. Hoffmeyer F, Raulf-Heimsoth M, Bruning T. Exhaled breath condensate and airway inflammation. Curr Opin Allergy Clin Immunol 2009;9:16-22.
11. Luczynska M, Szkudlarek U, Dziankowska-Bartkowiak B et al. Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis. Eur J Clin Invest 2003;33:274-9.
12. Carpagnano GE, Kharitonov SA, Wells AU, Pantelidis P, Du Bois RM, Barnes PJ. Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease. Respiration 2003;70:154-60.
13. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
14. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
15. Wuttge DM, Wildt M, Geborek P, Wollheim FA, Scheja A, Akesson A. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease. Arthritis Res Ther 2007;9:R85.
16. Tufvesson E, Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Resp Med 2006;100:34-8.
17. Tufvesson E, Bjermer L. Levels of cysteinyl-leukotrienes in exhaled breath condensate are not due to saliva contamination. Clin Resp J 2009;4:83-8.
18. Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189:693-8.
19. Kowal-Bielecka O, Kowal K, Distler O, Gay S. Mechanisms of disease: leukotrienes and lipoxins in scleroderma lung disease-insights and potential therapeutic implications. Nat Clin Pract Rheumatol 2007;3:43-51.
20. Kowal-Bielecka O, Kowal K, Highland KB, Silver RM. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum 2009; Jan 17 [Epub ahead of print].